Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4085327
Max Phase: Preclinical
Molecular Formula: C12H17N2O8P
Molecular Weight: 348.25
Molecule Type: Small molecule
Associated Items:
ID: ALA4085327
Max Phase: Preclinical
Molecular Formula: C12H17N2O8P
Molecular Weight: 348.25
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: COc1ccc([C@H](O)P(=O)(O)CC[C@H](N)C(=O)O)cc1[N+](=O)[O-]
Standard InChI: InChI=1S/C12H17N2O8P/c1-22-10-3-2-7(6-9(10)14(18)19)12(17)23(20,21)5-4-8(13)11(15)16/h2-3,6,8,12,17H,4-5,13H2,1H3,(H,15,16)(H,20,21)/t8-,12+/m0/s1
Standard InChI Key: HSHWJQGGJKYMDI-QPUJVOFHSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 348.25 | Molecular Weight (Monoisotopic): 348.0723 | AlogP: 0.67 | #Rotatable Bonds: 8 |
Polar Surface Area: 173.22 | Molecular Species: ZWITTERION | HBA: 7 | HBD: 4 |
#RO5 Violations: 0 | HBA (Lipinski): 10 | HBD (Lipinski): 5 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 0.97 | CX Basic pKa: 9.53 | CX LogP: -2.27 | CX LogD: -5.36 |
Aromatic Rings: 1 | Heavy Atoms: 23 | QED Weighted: 0.30 | Np Likeness Score: 0.18 |
1. Selvam C, Lemasson IA, Brabet I, Oueslati N, Karaman B, Cabaye A, Tora AS, Commare B, Courtiol T, Cesarini S, McCort-Tranchepain I, Rigault D, Mony L, Bessiron T, McLean H, Leroux FR, Colobert F, Daniel H, Goupil-Lamy A, Bertrand HO, Goudet C, Pin JP, Acher FC.. (2018) Increased Potency and Selectivity for Group III Metabotropic Glutamate Receptor Agonists Binding at Dual sites., 61 (5): [PMID:29397723] [10.1021/acs.jmedchem.7b01438] |
Source(1):